EMEA-001760-PIP01-15-M03 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0112/2019
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Lartruvo
olaratumab
Sarcoma
Date of authorisation:
Revision: 3
Last updated:
MedicineHumanRevoked
Lartruvo - referral
olaratumab
Article 20 procedures
Status: European Commission final decision
Opinion/position date:
EC decision date:
Last updated:
ReferralHuman
EMEA-000869-PIP01-10 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Pneumology-allergology
PIP number: -
Route(s) of administration: Sublingual use
Pharmaceutical form(s):
Oralmucosal drops
Decision date:
Last updated:
Compliance check: ✖
PIPHuman